Abstract:The molecular mechanisms used by olfactory ensheathing cells (OECs) to promote repair in the damaged adult mammalian CNS remain unknown. Thus, we used microarrays to analyze three OEC populations with different capacities to promote axonal regeneration in cultured rat retinal neurons. Gene expression in "long-term cultured OECs" that do not stimulate adult axonal outgrowth was compared with that of "primary olfactory ensheathing cells" and the immortalized OEC cell line TEG3. In this way, we identified a numbe… Show more
“…In addition, this cell line shows all the types of morphology described for primary OECs in culture (Moreno-Flores et al, 2006;. In a first set of experiments, we characterized the TEG3 cell line in our culture conditions (Fig.…”
Section: Resultsmentioning
confidence: 99%
“…Given their axon growth-promoting properties, natural or genetically modified OECs have been studied extensively and transplanted into the injured spinal cord to promote axonal regeneration (Ramon-Cueto and Nieto- Sampedro, 1994;Li et al, 1997;Ramon-Cueto et al, 1998;Navarro et al, 1999;Ramon-Cueto et al, 2000;Ruitenberg et al, 2002;Garcia-Alias et al, 2004;MorenoFlores et al, 2006). Thus, OEC transplantation has emerged as a promising therapy for spinal cord injuries and for other neural diseases (Moreno-Flores and Avila, 2006;Raisman, 2007;Ramon-Cueto and Munoz-Quiles, 2010). Several OEC subpopulations have been identified in the olfactory system on the basis of their topographical distribution, distinctive morphology, intracellular cytoskeletal distribution and antigenic or gene expression profiles (Au and Roskams, 2003;Vincent et al, 2005;Guerout et al, 2010;Windus et al, 2010).…”
SummaryNewly generated olfactory receptor axons grow from the peripheral to the central nervous system aided by olfactory ensheathing cells (OECs). Thus, OEC transplantation has emerged as a promising therapy for spinal cord injuries and for other neural diseases. However, these cells do not present a uniform population, but, instead, a functionally heterogeneous population that exhibits a variety of responses including adhesion, repulsion and crossover during cell-cell and cell-matrix interactions. Some studies report that the migratory properties of OECs are compromised by inhibitory molecules and potentiated by chemical gradients. Here, we demonstrated that rodent OECs express all the components of the Nogo Receptor complex and that their migration is blocked by Myelin. Next, we used cell tracking and traction force microscopy to analyze OEC migration and its mechanical properties over Myelin. Our data relate the absence of traction force of OEC with lower migratory capacity, which correlates with changes in the F-Actin cytoskeleton and focal adhesion distribution.Lastly, OEC traction force and migratory capacity is enhanced after cell incubation with the Nogo Receptor inhibitor NEP1-40.3
“…In addition, this cell line shows all the types of morphology described for primary OECs in culture (Moreno-Flores et al, 2006;. In a first set of experiments, we characterized the TEG3 cell line in our culture conditions (Fig.…”
Section: Resultsmentioning
confidence: 99%
“…Given their axon growth-promoting properties, natural or genetically modified OECs have been studied extensively and transplanted into the injured spinal cord to promote axonal regeneration (Ramon-Cueto and Nieto- Sampedro, 1994;Li et al, 1997;Ramon-Cueto et al, 1998;Navarro et al, 1999;Ramon-Cueto et al, 2000;Ruitenberg et al, 2002;Garcia-Alias et al, 2004;MorenoFlores et al, 2006). Thus, OEC transplantation has emerged as a promising therapy for spinal cord injuries and for other neural diseases (Moreno-Flores and Avila, 2006;Raisman, 2007;Ramon-Cueto and Munoz-Quiles, 2010). Several OEC subpopulations have been identified in the olfactory system on the basis of their topographical distribution, distinctive morphology, intracellular cytoskeletal distribution and antigenic or gene expression profiles (Au and Roskams, 2003;Vincent et al, 2005;Guerout et al, 2010;Windus et al, 2010).…”
SummaryNewly generated olfactory receptor axons grow from the peripheral to the central nervous system aided by olfactory ensheathing cells (OECs). Thus, OEC transplantation has emerged as a promising therapy for spinal cord injuries and for other neural diseases. However, these cells do not present a uniform population, but, instead, a functionally heterogeneous population that exhibits a variety of responses including adhesion, repulsion and crossover during cell-cell and cell-matrix interactions. Some studies report that the migratory properties of OECs are compromised by inhibitory molecules and potentiated by chemical gradients. Here, we demonstrated that rodent OECs express all the components of the Nogo Receptor complex and that their migration is blocked by Myelin. Next, we used cell tracking and traction force microscopy to analyze OEC migration and its mechanical properties over Myelin. Our data relate the absence of traction force of OEC with lower migratory capacity, which correlates with changes in the F-Actin cytoskeleton and focal adhesion distribution.Lastly, OEC traction force and migratory capacity is enhanced after cell incubation with the Nogo Receptor inhibitor NEP1-40.3
“…Immunohistochemistry was performed with antibodies that identified immunoreactivity for Neu-N, a nuclear protein found in the nuclei of mature neurons (1:1000 dilution; Chemicon-Millipore, Billerica, MA, USA), and for the NT receptors: p75 NTR , TrkB, TrkA and TrkC (all diluted 1:30; Santa Cruz Biotechnology, Santa Cruz, CA, USA). According to the manufacturers and as already verified in selected references [18,[44][45][46][47][48], these antibodies recognize a single band in western blot and show no cross-reactivity with other NT receptors. Briefly, paraffin embedded MTLE and control hippocampi were processed together for each antibody as described in Kandratavicius et al [7], with overnight incubation at room temperature and developed simultaneously for 10 min in 0.05% 3,3'-diaminobenzidine tetrahydrochloride (Pierce, Rockford, USA) and 0.01% hydrogen peroxide (Merck, Darmstadt, Germany).…”
Section: Tissue Collection and Immunohistochemical Processingmentioning
Epilepsy and psychiatric comorbidities are frequently associated, but their common biological substrate is unknown. We have previously reported altered structural elements and neurotrophins (NTs) expression in mesial temporal lobe epilepsy (MTLE) patients with psychiatric comorbidities. NTs receptors can regulate neurotransmission and promote neuroplasticity, being important candidates in the regulation and manifestation of psychopatological states and seizure-related events. MTLE hippocampi of subjects without psychiatric history, MTLE + major depression, MTLE + interictal psychosis derived from epilepsy surgery, and control necropsies were investigated for p75 NTR , TrkB, TrkA, and TrkC immunohistochemistry. Increased expression of p75 NTR , decreased TrkA, unaltered TrkC, and complex alterations involving TrkB expression were seen in MTLE groups. Increased TrkB expression in patients without complete seizure remission and in those with secondarily generalized seizures was seen. Decreased p75 NTR expression associated with interictal psychosis, and increased TrkB in those with psychosis or major depression was also reported, although their p75 NTR /TrkB ratios were lower than in MTLE without psychiatric comorbidities. Our results provide evidence of alterations in expression of NTs receptors in the epileptogenic hippocampus that are differentially modulated in presence of psychiatric comorbidities. As already explored in animal models, even in chronic human MTLE increased TrkB expression, among other NT receptors alterations, may play a major role in seizure type, frequency and surgery outcome.
“…Furthermore, the downregulation of MMP-2 and MMP-9 also suppresses cell migration. [25][26][27] NCAM1, which is a major component of OEC-induced corticospinal axon elongation, plays a key role in OEC migration. 28,29) The RT-PCR findings indicate that ginsenoside Rg1 increased the expression of MMP-2, MMP-9, and NCAM1 genes, which stimulate ginsenoside Rg1 in enhancing the migration characteristic of OECs.…”
The aim of this study was to determine the effects of ginsenoside Rg1 on the migration of olfactory ensheathing cells (OECs) in vitro, and its influence on the therapeutic efficacy of OECs transplanted in vivo for the treatment of spinal cord injury (SCI). Primary cultured and purified OECs (prepared from rats) were treated with ginsenoside Rg1. The wound healing test indicated that ginsenoside Rg1 promoted the migration of OECs. Real-time RT-PCR demonstrated that ginsenoside Rg1 upregulated the expression of migration-related factors of OECs, including matrix metalloproteinases-2 (MMP-2), MMP-9, and neural cell adhesion molecule 1 (NCAM1). Moreover, Western blot analysis indicated that ginsenoside Rg1 significantly promoted the migration of OECs via the phosphatidylinositol 3-kinase (PI3K)/Akt pathway. An SCI rat model was induced in vivo using a revised Allen's method. The Basso, Beattie, and Bresnahan (BBB) scores and histological analysis demonstrated that OECs, which were treated with ginsenoside Rg1, exhibited significant improvement in SCI compared with both the control group and the OEC group. Thus, ginsenoside Rg1 may represent a novel treatment target for SCI.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.